Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis? - Wikidata - wikimedia - TriplyDB

Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?

Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?

http://www.wikidata.org/entity/Q42988617

about

Vitamin D and Chronic Diseases Vitamin D and GI cancers: shedding some light on dark diseases Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells.The emerging role of mast cells in liver disease.Role of superoxide dismutase in hepatitis B virus-related hepatocellular carcinoma The fibrolytic potentials of vitamin D and thymoquinone remedial therapies: insights from liver fibrosis established by CCl4 in rats Neutralization of Interleukin-17 Attenuates Cholestatic Liver Fibrosis in Mice.Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review.Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D.Vitamin D serum levels and receptor genetic polymorphisms are associated with hepatitis B virus and HIV infections and IFN-λ levels.

P2860

Q33714268-5E033C37-147A-4275-BFCB-375922A45F30 Q34357880-E08A5663-9952-4A7F-BBBC-D85C20164735 Q35903848-CA439CD0-4CBE-4DF6-A3E7-70C138700EFA Q37022338-942F71F5-D85D-408E-B167-3BE3A5405CBB Q39284642-6BD78EBE-0EFB-498F-AA28-18142FDB679C Q40348837-D4457F9B-2110-463C-9FE8-BA0A00D3741F Q40408671-51483F8F-813C-480A-A0DB-F732DF42F335 Q40410801-637FEF94-0CDA-4DA8-9987-742C6ADEA0C8 Q49216676-937540BC-C873-4898-B7F6-1702BBE23D5F Q49722254-CA268139-AC0D-4253-9903-F5B65D901AA4 Q54264283-B5FC386A-23EB-47B9-BC11-76831F1B26C9

P2860

Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?

http://www.wikidata.org/entity/Q42988617

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@en

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@nl

type

label

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@en

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@nl

prefLabel

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@en

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@nl

P1433

Q42988617-FF908F5C-9D76-4C99-8A47-2D1CBE93A611

P1476

Q42988617-ECFE708D-ABB6-43C9-9378-22824A677CE5

P2093

Q42988617-6828558B-42E1-4CE5-A104-51FE269A35BC

Q42988617-6E7FA61D-6D67-48C4-946C-F2640F94FCC3

Q42988617-A71BA403-A55A-422B-8212-99C2E884C0A5

Q42988617-BA8C0778-99FC-4A76-87B6-2619940AD087

Q42988617-C69D2CEF-0E34-41A9-A805-0FD36EC39E62

P2860

Q42988617-06DF3D0B-50BC-41BD-A9ED-6839D9054E30

Q42988617-12440D9E-56E4-4D09-AC48-40EC671FAA1C

Q42988617-1A570AA0-80D7-4619-89AE-D5A3394CE8BC

Q42988617-21BF26F0-E6AE-4DC0-8ABC-F90D76EE0D77

Q42988617-2B63167C-2FBD-432D-9E4A-ADA77FFC3144

Q42988617-38F57843-A1DF-4561-BB57-79B6C890FC16

Q42988617-3997F844-81F8-4BDF-9658-7746EF332717

Q42988617-412AE880-29F0-466B-BBEF-BD23E783B17C

Q42988617-5B9216A2-4958-4AD9-9316-D1E7BD5263EE

Q42988617-5FBDA525-BCEC-4005-BA5A-289EE8D93C35

P304

Q42988617-CB0A3C9C-2D8F-446A-858C-3AFECFD14957

P31

Q42988617-72C6C165-480D-4E83-9D84-6D2D83E87EE0

P356

Q42988617-0F295753-5400-4C78-AD54-A1904C2A33A1

P433

Q42988617-537A7010-7C9B-4640-90AD-6F69EF1E57D2

P478

Q42988617-D0B54E47-C2C3-4423-A6C3-28DA824AB03D

P577

Q42988617-EC5EDFAE-48B6-49B1-B4FF-CF434767917A

P698

Q42988617-A5559D33-40FD-466B-9964-0230C6946E50

P921

Q42988617-86406B62-8D1E-465D-BF36-2C36D83193B2

Q42988617-FEA5753D-1AA8-4B01-A5AF-808230408558

P356

1547691X.2012.758198

P1433

Journal of Immunotoxicology

P1476

Circulating IL-6, IL-17 and vi ...... or a more favorable prognosis?

@en

P2093

Fetouh S Hassanein

http://www.w3.org/2001/XMLSchema#string

Lamiaa N Hammad

http://www.w3.org/2001/XMLSchema#string

Mona F Schaalan

http://www.w3.org/2001/XMLSchema#string

Sahar M Abdelraouf

http://www.w3.org/2001/XMLSchema#string

Walid A Mohamed

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients

IL-17 and Th17 Cells

IL-17 family cytokines and the expanding diversity of effector T cell lineages

Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.

Clinical implications of alpha-fetoprotein in chronic hepatitis C.

Vitamin D, the immune system and asthma

Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.

Th17 mediators and vitamin D status.

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma.

P304

380-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/1547691X.2012.758198

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23350952

http://www.w3.org/2001/XMLSchema#string

P921